These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 15275730)
1. The role of abdominal-pelvic radiotherapy in the management of uterine papillary serous carcinoma. Kwon J; Ackerman I; Franssen E Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1439-45. PubMed ID: 15275730 [TBL] [Abstract][Full Text] [Related]
3. The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma. Hamilton CA; Cheung MK; Osann K; Balzer B; Berman ML; Husain A; Teng NN; Kapp DS; Chan JK Gynecol Oncol; 2006 Nov; 103(2):679-83. PubMed ID: 16793126 [TBL] [Abstract][Full Text] [Related]
4. Uterine papillary serous carcinoma: patterns of failure and survival. Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700 [TBL] [Abstract][Full Text] [Related]
5. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Kelly MG; O'malley DM; Hui P; McAlpine J; Yu H; Rutherford TJ; Azodi M; Schwartz PE Gynecol Oncol; 2005 Sep; 98(3):353-9. PubMed ID: 16005947 [TBL] [Abstract][Full Text] [Related]
6. Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006. Tchabo NE; McCloskey S; Mashtare TL; Andrews C; Singh AK; Mhawech-Fauceglia P; Odunsi K; Lele S; Jaggernauth W Gynecol Oncol; 2009 Nov; 115(2):249-56. PubMed ID: 19692115 [TBL] [Abstract][Full Text] [Related]
7. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN). Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; VillĂ S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A; Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209 [TBL] [Abstract][Full Text] [Related]
8. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. Thomas MB; Mariani A; Cliby WA; Keeney GA; Podratz KC; Dowdy SC Gynecol Oncol; 2007 Nov; 107(2):186-9. PubMed ID: 17688926 [TBL] [Abstract][Full Text] [Related]
9. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation. Kelly MG; O'Malley D; Hui P; McAlpine J; Dziura J; Rutherford TJ; Azodi M; Chambers SK; Schwartz PE Gynecol Oncol; 2004 Dec; 95(3):469-73. PubMed ID: 15581948 [TBL] [Abstract][Full Text] [Related]
10. Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC). Fields AL; Einstein MH; Novetsky AP; Gebb J; Goldberg GL Gynecol Oncol; 2008 Jan; 108(1):201-6. PubMed ID: 17997145 [TBL] [Abstract][Full Text] [Related]
11. Role of cytoreduction in stage III and IV uterine papillary serous carcinoma. Thomas MB; Mariani A; Cliby WA; Keeney GL; Podratz KC; Dowdy SC Gynecol Oncol; 2007 Nov; 107(2):190-3. PubMed ID: 17825394 [TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study. Fakiris AJ; Moore DH; Reddy SR; Look KY; Yiannoutsos CT; Randall ME; Cardenes HR; Gynecol Oncol; 2005 Mar; 96(3):818-23. PubMed ID: 15721431 [TBL] [Abstract][Full Text] [Related]
13. Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients. Grice J; Ek M; Greer B; Koh WJ; Muntz HG; Cain J; Tamimi H; Stelzer K; Figge D; Goff BA Gynecol Oncol; 1998 Apr; 69(1):69-73. PubMed ID: 9571001 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma. Low JS; Wong EH; Tan HS; Yap SP; Chua EJ; Sethi VK; Soh LT; Low J; Tay EH; Chew SH Gynecol Oncol; 2005 Apr; 97(1):171-7. PubMed ID: 15790454 [TBL] [Abstract][Full Text] [Related]
15. Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study. Mahdi H; Elshaikh MA; DeBenardo R; Munkarah A; Isrow D; Singh S; Waggoner S; Ali-Fehmi R; Morris RT; Harding J; Moslemi-Kebria M Gynecol Oncol; 2015 May; 137(2):239-44. PubMed ID: 25641568 [TBL] [Abstract][Full Text] [Related]
16. Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging? Kwon JS; Abrams J; Sugimoto A; Carey MS Int J Gynecol Cancer; 2008; 18(4):820-4. PubMed ID: 17892450 [TBL] [Abstract][Full Text] [Related]
17. Impact of adjuvant external-beam radiation therapy in early-stage uterine papillary serous and clear cell carcinoma. Kim A; Schreiber D; Rineer J; Choi K; Rotman M Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e639-44. PubMed ID: 21507584 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group. Sutton G; Axelrod JH; Bundy BN; Roy T; Homesley H; Lee RB; Gehrig PA; Zaino R Gynecol Oncol; 2006 Feb; 100(2):349-54. PubMed ID: 16213007 [TBL] [Abstract][Full Text] [Related]
19. Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma. Rauh-Hain JA; Growdon WB; Schorge JO; Goodman AK; Boruta DM; McCann C; Horowitz NS; del Carmen MG Gynecol Oncol; 2010 Nov; 119(2):299-304. PubMed ID: 20691465 [TBL] [Abstract][Full Text] [Related]
20. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]